Author Topic: Pro and con about whether rituximab is an acceptable alternative to ocrelizumab  (Read 143 times)

0 Members and 2 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Multiple Sclerosis Journal often publishes a "yes" and "no" side to a debate, accompanied by a commentary. The August issue's debate topic is whether rituximab is an acceptable alternative to ocrelizumab in treating MS.


The "Yes" side:


http://journals.sagepub.com/doi/full/10.1177/1352458518757930


The "No" side:


http://journals.sagepub.com/doi/full/10.1177/1352458518757931


And the Commentary:


http://journals.sagepub.com/doi/full/10.1177/1352458518760717
« Last Edit: August 04, 2018, 11:26:41 am by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
467 Views
Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
61 Views
Last post February 10, 2021, 09:39:05 pm
by agate
0 Replies
29 Views
Last post November 01, 2022, 09:38:58 pm
by agate
4 Replies
2365 Views
Last post November 27, 2023, 04:18:36 pm
by agate
0 Replies
15 Views
Last post December 04, 2023, 11:04:57 am
by agate